FNDC5 and cancer: We subsequently exposed MM cells to 10 nM r-irisin, corresponding to the dose of irisin reported to exhibit biological activity in vitro [37], to assess whether irisin might interfere with cancer cell invasiveness across the extracellular matrix (ECM).